News
-
-
PRESS RELEASE
Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes
Abbott receives CE Mark for first dual glucose-ketone sensing technology for diabetes management, providing real-time visibility into glucose and ketone levels. Integration with Libre ecosystem and AID systems -
-
PRESS RELEASE
Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management
Abbott announces results from the FreeDM2 study showing that FreeStyle Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management. Real-time insights led to better outcomes -
PRESS RELEASE
Less Is More: Abbott’s Approach to Packaging Innovation
